Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia
Condition: Bronchopulmonary Dysplasia Intervention: Biological: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Sponsors: Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); Ontario Institute of Regenerative Medicine (OIRM); Stem Cell Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bronchopulmonary Dysplasia | Research